The 6th Annual Psychedelic Therapeutics and Drug Development Conference is set to convene in New Orleans, LA, on February 26-27, 2026. This event aims to unite leading researchers and professionals from academia, industry, non-profit, and government sectors to explore the challenges and opportunities in psychedelic research and development. Attendees will gain insights into the progress towards regulatory approval of psychedelics for treating various conditions, including PTSD, anxiety, depression, and more. The conference will feature discussions on clinical trial design, intellectual property, regulatory guidance, and commercialization, among other topics. Participants will have the opportunity to network with peers and discover innovative tools and methodologies in the field. The agenda includes sessions on clinical trial design, legal challenges, drug development, and more, providing a comprehensive overview of the current landscape and future directions in psychedelic research.
Mental Health Conferences
The 6th Annual Psychedelic Therapeutics & Drug Development Conference
The 6th Annual Psychedelic Therapeutics and Drug Development Conference will be held in New Orleans, LA, on February 26-27, 2026. This event gathers leading researchers and industry professionals to discuss the development of psychedelics for health conditions with unmet needs.
Conference Overview
Some quick details about this conference.
Time and Place
Maybe the most important details of the conference.
Conference Dates: February 26–27, 2026
City/State: New Orleans, Louisiana
Event Format: in-person
Conference Organizer
This organization is hosting this conference.
Arrowhead Publishers
Arrowhead Sci-Tech Conferences & Events focus on bringing life sciences industry professionals together to help move research forward.
Email: enquiries@arrowheadpublishers.com
Phone: +1 866-945-0263
Schedule and Agenda
It's important to know what is planned.
The conference will cover a wide range of topics, including clinical trial design, regulatory challenges, and commercialization strategies. Sessions will feature leading experts discussing the latest advancements in psychedelic research and therapy.
Notable Speakers
These folks will be speaking at the conference.
Mark Theeuwes
Chief Operating Officer at Reunion Neuroscience
Todd Solomon, Ph.D.
Director of Global Development at MindMed
Matias Serebrinsky
General Partner & Co-Founder at Psymed Ventures
Joshua Woolley, MD
Associate Professor at UC San Francisco
Hailey Gilmore
Clinical Program Manager at Lykos Therapeutics
Tim Schlidt
Co-Founder & Partner at Palo Santo
Matthew Baggott, Ph.D.
Co-Founder & CEO at Tactogen
Boris Heifets, MD
Associate Professor at Stanford University
Alan Kozikowski, Ph.D.
Chief Scientific Officer at PurMinds Neuropharma
Peter Hendricks, Ph.D.
Professor of Public Health at Univ. of Alabama Birmingham
Deborah Mash, Ph.D.
Chief Executive Officer & Founder at DemeRx
Charles Nichols, Ph.D.
Professor at LSU Health Sciences Center
Bernard Lerer, MD
Professor of Psychiatry at Hebrew University
Ed Christian, Ph.D.
Exec. Dir. Clinical Science at Gilgamesh Pharmaceuticals
Natalie Gukasyan, MD
Assistant Professor at Columbia University
Sponsorship, Exhibitor, and Advertising Opportunities
If you're an organization that wants to contribute to this event, here are some details.
Organizations interested in sponsoring or exhibiting at the conference can explore opportunities in clinical trial services, manufacturing, preclinical research, and technology solutions. More information can be found on the Sponsor/Exhibit page.
Other Links and Information
The above information is from the conference or event webpage. Please review the organization's website for official information, as that will be more up-to-date.
Reminder: This is an overview of this conference, and you should consult the official website for details on registration, fees, deadlines, and other details. Quill Therapy Solutions is maintaining this information to make it more accessible to the therapist and mental health professional community.
If you noticed an issue with the above information, please send us an email: conferences@quilltherapysolutions.com (Ideally, include a link to the conference and the details that need to be corrected. Thank you!)
About Quill
Quill helps you create detailed therapy notes quickly while maintaining the highest standards of privacy and ethics. Try it today and experience documentation that aligns with your values.